Dissolvable heart stent could replace permanent implants

NCT ID NCT06919562

Recruiting now Disease control Sponsor: Albert Schweitzer Ziekenhuis, Netherlands Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new type of heart stent that dissolves over time, unlike permanent metal stents. The trial will enroll 117 people with stable coronary artery disease to see if the new stent, placed with special imaging guidance, works safely and effectively. The goal is to reduce long-term problems like inflammation and make future heart surgeries easier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MeRes100 thin-strut bioresorbable scaffold
What this could lead to: If successful, this could lead to a safer way to open blocked heart arteries that dissolves over time, potentially reducing long-term complications from permanent stents.
What could go wrong: This is a small, early feasibility study (117 people) testing a new device and technique. The scaffold may still cause blood clots or fail to perform as well as current standard stents.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERIAL DISEASE (CAD) PERCUTANEOUS CORONARY INTERVENTION (PCI)

Contacts and locations

Locations

Albert Schweitzer ziekenhuis
RECRUITING

Dordrecht, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.